The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year ...
Aurora Cannabis Inc. closed 52.83% short of its 52-week high of $9.35, which the company reached on April 30th.
Aurora Cannabis Inc. closed 54.01% short of its 52-week high of $9.35, which the company achieved on April 30th.
Aurora Cannabis CEO Miguel Martin thinks the cannabis industry and its investors are too focused on US recreational consumers and are missing a more profitable opportunity: medical marijuana.
Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good investment right now? Aurora Cannabis produces and sells a variety of ...
Aurora Cannabis has transformed its margins, market position, and balance sheet over the last few years, and the stock is now highly 'investible'. ACB's strategic focus on the global medical ...
Canada & Portugal lead supply. Javier Hasse This Week In Cannabis: DeSantis' Anti-Weed Push, NY's Drug Decriminalization, Aurora's Record Earnings, Tilray And More Global News Cannabis news ...
EDMONTON, AB, Feb. 20, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the company's extended pastille ...
Analysts raised concerns about potential pricing impacts from increased competition in global medical cannabis markets. Martin emphasized Aurora’s competitive advantages, including regulatory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results